Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)

SHE:002737 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	940	1,040	2,287	2,399	1,320	1,648
Short-Term Investments	-	-	-	-	304.42	-
Trading Asset Securities	1,460	1,258	1,315	1,449	668.69	150.49
Cash & Short-Term Investments	2,400	2,298	3,602	3,847	2,293	1,798
Cash Growth	-36.79%	-36.19%	-6.38%	67.77%	27.52%	7.63%
Accounts Receivable	556.48	584.93	110.13	184.25	268.98	286.85
Other Receivables	16.65	14.95	41.42	42.57	12.21	24.16
Receivables	573.13	599.88	151.56	226.82	281.19	311.02
Inventory	786.66	867.31	873.19	632.08	709.64	562.17
Prepaid Expenses	-	31.68	44.3	3.74	8.75	-
Other Current Assets	122.93	88.23	116.81	151.03	100.11	265.69
Total Current Assets	3,883	3,886	4,788	4,861	3,393	2,937
Property, Plant & Equipment	1,260	1,311	1,435	1,497	1,577	1,609
Long-Term Investments	91.35	97.12	122.44	141.38	131.32	3.09
Goodwill	86.98	86.98	91.77	91.77	107.6	134.82
Other Intangible Assets	326.12	332.64	345.37	366.52	337.77	350.8
Long-Term Deferred Tax Assets	51.08	37.62	58.92	56.51	55.78	59.5
Long-Term Deferred Charges	9.05	10.03	8.86	6.81	1.87	3.76
Other Long-Term Assets	67.22	64.89	31.39	10.85	30.77	15.31
Total Assets	5,774	5,826	6,882	7,032	5,635	5,113
Accounts Payable	327.9	319.05	734.6	714.48	547.18	447.88
Accrued Expenses	134.59	237.36	259.07	301.01	124.75	111.67
Short-Term Debt	-	0.02	14.43	420	200	240.52
Current Portion of Leases	4.04	4.95	4.46	5.59	3.5	-
Current Income Taxes Payable	33.99	4.73	87.53	60.21	43.54	70.36
Current Unearned Revenue	236.98	285.68	297.32	551.54	167.04	121.21
Other Current Liabilities	198.45	175.74	122.5	122.54	166.6	166.4
Total Current Liabilities	935.95	1,028	1,520	2,175	1,253	1,158
Long-Term Debt	-	-	-	-	33.57	70.01
Long-Term Leases	3.6	4.03	7.62	10.5	7.01	-
Long-Term Unearned Revenue	181.48	199.37	342.08	397.26	389.08	380.37
Long-Term Deferred Tax Liabilities	4.62	4.95	7.61	9.89	17.82	20.23
Other Long-Term Liabilities	-	-	-	-	-	93.93
Total Liabilities	1,126	1,236	1,877	2,593	1,700	1,723
Common Stock	584	584	584	584	584	584
Additional Paid-In Capital	918.43	918.43	915.66	889.99	896.7	930
Retained Earnings	2,925	2,868	3,252	2,716	2,256	1,753
Treasury Stock	-	-	-	-	-44	-106.33
Comprehensive Income & Other	9.16	9.16	12.28	14.38	16.77	19.47
Total Common Equity	4,436	4,379	4,763	4,205	3,709	3,180
Minority Interest	212.51	210.86	241.25	234	225.72	210.53
Shareholders' Equity	4,649	4,590	5,005	4,439	3,935	3,391
Total Liabilities & Equity	5,774	5,826	6,882	7,032	5,635	5,113
Total Debt	7.64	8.99	26.52	436.08	244.08	310.53
Net Cash (Debt)	2,392	2,289	3,576	3,411	2,049	1,488
Net Cash Growth	-36.54%	-35.97%	4.82%	66.47%	37.72%	19.56%
Net Cash Per Share	4.10	3.91	6.13	5.82	3.52	2.55
Filing Date Shares Outstanding	584	584	584	584	587.54	576.87
Total Common Shares Outstanding	584	584	584	584	587.54	576.87
Working Capital	2,947	2,858	3,268	2,686	2,140	1,779
Book Value Per Share	7.60	7.50	8.16	7.20	6.31	5.51
Tangible Book Value	4,023	3,960	4,326	3,746	3,264	2,695
Tangible Book Value Per Share	6.89	6.78	7.41	6.42	5.56	4.67
Buildings	-	1,567	1,612	1,604	1,589	1,389
Machinery	-	1,121	1,075	1,014	982.56	906.81
Construction In Progress	-	30.84	35.7	30.29	19.15	216.6

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.